Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic, and there is no standard and efficient therapy for it. Chitosan oligosaccharide (COS) is widely known to have various biological effects, and in this study we aimed to evaluate the liver-protective effect in diet-induced obese mice for a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Minyi, Lyu, Qianqian, Liu, Yujie, Hu, Haiyang, Wang, Shilei, Pan, Chuyue, Duan, Xubin, Gao, Yingsheng, Qi, Lian-wen, Liu, Weizhi, Wang, Lirui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669476/
https://www.ncbi.nlm.nih.gov/pubmed/31269758
http://dx.doi.org/10.3390/md17070391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669476/
https://www.ncbi.nlm.nih.gov/pubmed/31269758
http://dx.doi.org/10.3390/md17070391

Ejemplares similares